Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Cash & Current Investments (2009 - 2026)

Updated

Elite Pharmaceuticals' Cash & Current Investments was $35.34 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 30.5% from $27.08 million a year earlier but down 10.3% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Cash & Current Investments at Elite Pharmaceuticals came in at $30.27 million, up 157.2% from FY2025.

  • Cash & Current Investments shows a five-year compound annual growth rate of 56.8% (FY2021 to FY2026).
  • In earlier fiscal years, Cash & Current Investments was $11.77 million in FY2025 (+56.1%), $7.54 million in FY2024 (-8.6%), $8.24 million in FY2023 (-3.4%) and $8.54 million in FY2022 (+167.3%).
  • Quarterly Cash & Current Investments has moved between $6.24 million (fiscal Q3 2024) and $39.42 million (fiscal Q1 2027) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for nine straight quarters, with growth averaging 103.7% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q1 2023 (growth of 316.3%); the worst was fiscal Q3 2024 (a decline of 65.1%).
  • Per Business Quant data, ELTP's Cash & Current Investments in the three fiscal quarters before Q2 2027 was $39.42 million (Q1 2027), $30.27 million (Q4 2026) and $21.56 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.23 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 505.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.96 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 14.27 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 35.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 35.34 Mn
Jun 30, 2026 39.42 Mn
Mar 31, 2026 30.27 Mn
Dec 31, 2025 21.56 Mn
Sep 30, 2025 27.08 Mn
Jun 30, 2025 22.20 Mn
Mar 31, 2025 11.77 Mn
Dec 31, 2024 8.74 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 8.85 Mn
Mar 31, 2024 7.54 Mn
Dec 31, 2023 6.24 Mn
Sep 30, 2023 9.08 Mn
Jun 30, 2023 9.49 Mn
Mar 31, 2023 8.24 Mn
Dec 31, 2022 17.91 Mn
Sep 30, 2022 18.56 Mn
Jun 30, 2022 19.78 Mn
Mar 31, 2022 8.54 Mn
Dec 31, 2021 7.29 Mn
API Access

Elite Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELTP&period=max&api_key=YOUR_API_KEY